Moleculin Biotech Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.64

-0.93 (-26.05%)

As of Jun 30, 4:31 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +863.3% upside

Low Target $14.54

Average Target $25.43

High Target $32.33

Current Price $2.64

Current
$2.64

Target
$25.43

$14.54 $25.43 avg $32.33

Scenario Analysis

Bear Case

$14.54

450.8%

Low target

Base Case

$25.43

+863.3%

Avg target

Bull Case

$32.33

+1,124.6%

High target

Risk/Reward

2.5x

Favorable

Price in Context

52-Week High

$24.00

-89.0% from high

52-Week Low

$1.79

+47.5% from low

Target vs 52W High

$25.43

+6.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%